Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-29FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Amiodarone Hydrochloride from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter [Phase 4]
Phase 4 clinical trial comparing bolus versus intravenous push diltiazem for atrial fibrillation or flutter with rapid ventricular response;…
-
FDA approval · 2019-10-04FDA Approved: DIGOXIN — Original Application (VistaPharm, LLC)
The FDA approved VistaPharm’s original (ANDA) application for digoxin, granting marketing approval for a generic digoxin product.
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
FDA approval · 2019-09-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
-
FDA approval · 2019-08-14FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Gland Pharma Limited)
The FDA approved the original abbreviated application for esmolol hydrochloride from Gland Pharma Limited, confirming a generic esmolol hydr…
-
FDA approval · 2019-08-08FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus [NA]
Clinical trial update on the Amigo Robotic System for ablation of the cavo-tricuspid isthmus in atrial fibrillation and atrial flutter; stud…
-
FDA approval · 2019-06-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved Ingenus Pharmaceuticals' generic diltiazem hydrochloride via an original ANDA submission.
-
FDA approval · 2019-02-22FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II [NA]
This clinical trial update indicates that the Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation study for atrial flutter has …
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: Intracardiac Echocardiography in Atrial Flutter Ablation [Phase 3]
A Phase 3 clinical trial evaluating intracardiac echocardiography in atrial flutter ablation has completed.
-
FDA approval · 2019-01-22FDA Approved: DOFETILIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic dofetilide from Aurobindo Pharma Limited. The approval makes a generic version of the an…
-
FDA approval · 2019-01-04FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Vitruvias Therapeutics)
FDA approved Propafenone hydrochloride as an Abbreviated New Drug Application (ANDA) for a generic antiarrhythmic, with Vitruvias Therapeuti…
-
FDA approval · 2018-12-28FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Armas Pharmaceuticals Inc.)
FDA approves Armas Pharmaceuticals' verapamil hydrochloride as an original ANDA generic; standard indications for verapamil HCl include hype…
-
CLINICAL_TRIALS research · 2018-10-25Clinical Trial Update: Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation [NA]
A completed clinical trial evaluating the impact of an atrial fibrillation decision support tool on thromboprophylaxis decisions in atrial f…
-
FDA approval · 2018-10-09FDA Approved: DOFETILIDE — Original Application (NorthStar RxLLC)
FDA approves NorthStar RxLLC's generic dofetilide for the maintenance of normal sinus rhythm in adults with atrial fibrillation or atrial fl…
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-24FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Hikma Pharmaceuticals USA Inc.
-
FDA label_change · 2018-08-24FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
FDA approves a supplemental application for LANOXIN (digoxin) filed by Covis Pharma US, Inc., resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter [Phase 4]
Phase 4 clinical trial evaluating a potassium infusion to convert atrial fibrillation or atrial flutter has completed.
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Verapamil Hydrochloride by Somerset Therapeutics, LLC, enabling a generic version of verapamil…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics' Verapamil hydrochloride as an original application, granting a generic version of the drug.
-
FDA approval · 2018-06-08FDA Approved: ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved esmolol hydrochloride in sodium chloride injection (ANDA) from Mylan Institutional LLC for short-term control of heart rate in …